NCT06893536 Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma
| NCT ID | NCT06893536 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Pancreatic Adenocarcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-10-12 |
| Primary Completion | 2025-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-10-12 with a primary completion date of 2025-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients with pancreatic adenocarcinoma are frequently in a situation of malnutrition, in a context of functional alteration of the digestive tract, and hypercatabolism. As a result, nutritional support is frequently necessary perioperatively, but currently does not follow a specific protocol, and without coordination. It then appears the need to evaluate the prevalence of malnutrition, its impact on perioperative morbidity and mortality, and current management methods. Depending on the findings, subsequent interventional studies will be carried out on the subject, exploring the different modalities of artificial nutrition.
Eligibility Criteria
Inclusion Criteria: * Major subject (≥18 years old) * Subject with pancreatic adenocarcinoma authenticated by pathology * Subject candidate for curative surgical treatment * Subject operated on in the visceral and digestive surgery department, NHC Strasbourg, during the period from January 1, 2018 to December 31, 2022 * Absence of written opposition in the subject's medical file to the reuse of their data for scientific research purposes. Exclusion criteria: * Subject having expressed opposition to participating in the study * Subject presenting a metastatic form or one not accessible to surgical treatment considered curative of pancreatic adenocarcinoma * Subject under guardianship or curatorship * Subje
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06893536 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Adenocarcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06893536 currently recruiting?
Yes, NCT06893536 is actively recruiting participants. Contact the research team at zineb.cherkaoui@chru-strasbourg.fr for enrollment information.
Where is the NCT06893536 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT06893536 clinical trial?
NCT06893536 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 100 participants.